Dole Announces its Promises, Bringing Interdependent Prosperity to People and the Planet
30.6.2020 10:00:00 EEST | Business Wire | Press release
Dole Packaged Foods and Dole Asia Fresh, divisions of Dole Asia Holdings Pte. Ltd.. announced today “The Dole Promise,” which aims to increase access to sustainable nutrition, decrease food waste, plastics in packaging and carbon emissions and grow value for the company’s stakeholders, including farmers and shareholders.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200630005347/en/
The Dole Promise, inspired by Japanese philosophy, Sampo Yoshi. (Graphic: Business Wire)
“The Dole Promise reflects the recognition that 'business as usual' is unacceptable in the face of a looming food crisis and the growing expectations of the next generation," said Pier Luigi Sigismondi, President of Dole Packaged Foods. “The impacts of the COVID-19 global pandemic could see 265 million additional people pushed to the brink of starvation by the end of this year,1 double the numbers of last year. At the same time, the challenges of climate change, resource waste and declining natural resources still must be addressed. We believe it is time for a change, and we are taking action where we can be most effective – within our own business.”
The promise draws on the spirit of ‘Sampo Yoshi,’ an 18th century Japanese philosophy that views the well-being of society and business as interdependent, and ensures the business is beneficial to the seller, to the buyer and to the community.
“The triple-win concept of ‘Sampo Yoshi’ has been part of Japanese culture for centuries, and is now at the heart of The Dole Promise as we play our part in helping to restore balance in the world by doubling down on our mission to put the health of the planet at the heart of everything we do,” said Richard Toman, President Dole Asia Fresh Division. “It’s a promise that Dole is making to do business differently, and to join forces with those who are equally committed to bringing back the goodness of the earth.”
The Dole Promise frames this philosophy to include:
Better for People:
- Access to sustainable nutrition for 1 billion people by 2025
- Moving towards zero processed sugar in all Dole products by 2025
Better for Planet:
- Moving towards zero fruit loss from Dole farms to markets by 2025
- Moving towards zero fossil-based plastic packaging by 2025
- Aiming for net zero carbon emissions in Dole operations by 2030
Better for all Stakeholders:
- Dole will continue to positively impact all farmers, communities and people working for Dole – through its commitment to equal opportunity, living wages, and an ever-increasing level of safety, nutrition, and wellbeing. The company also seeks to advance human rights within the direct operations and supply chains by building a culture of transparency and accountability. The company also aims for a 50% increase in the value of its business by 2025.
The growing problem of food inequality, which existed before the pandemic, has now reached crisis proportions and needs a collective effort to address. Dole’s commitment to increase access to sustainable nutrition will play a role, along with its effort to eliminate food waste.
“Our promise is not just about improving our world today,” said Sigismondi. "We have a responsibility to future generations to work towards a more equitable and sustainable future.”
The launch video, “Dear Leaders of the World,” gives voice to the concern of today’s youth about their generation’s future if something doesn’t change now.
“The next generation is right to question why we have left problems like climate change for so long. There are inter-generational repercussions. That is why we are increasing our efforts in key areas like reducing carbon emissions and working towards removing plastic packaging from our supply chain. Our promise puts the heart of the planet and people at the center of everything we do,” added Sigismondi.
Elevating the end-to-end value chain
Addressing the many gaps in access to good nutrition and reduction of waste cannot be done alone. Dole is partnering with Solidaridad; an international civil society organization with over fifty years of experience in creating fair and sustainable supply chains from producer to consumer across five continents. They are developing innovative solutions for healthy and sustainable food systems ensuring that farmers and workers have a living income, influence over their destiny, and can produce in balance with nature. Dole is also enlisting the help of Forum for the Future, an organisation that works in partnership with business, governments and civil society to accelerate the shift toward a sustainable future, Future Food Institute a center of excellence for food intelligence and the food innovation ecosystem and Rocana, a venture capital firm focused on clean and functional nutrition.
Later this year, Dole is launching the Sunshine for All™ Investment Fund to support additional strategic partnerships and strategic investments in these areas around the world. The US$2 million annual fund will work with innovators, start-ups and progressive partners to help deliver on the Dole Promise in key areas such as nutrition products, materiality, advisory and implementation of crucial practices to help achieve the ambitions that have been set.
Additionally, Dole is bringing these commitments inside their company walls, with employee programs that educate and encourage all Dole employees to live “The Dole Promise.”
To see the full details of the Dole Promise and the Sunshine for All investment fund visit sunshineforall.com and download the Dole Promise visual here .
Dole Asia Holdings Pte. Ltd.
Dole Asia Holdings Pte. Ltd., is a worldwide leader and innovator in the production and marketing of high-quality packaged fruit and healthy snacks. Dole Asia Holdings is also one of Asia's largest producers and marketers of high-quality fresh fruits and vegetables. For more information please visit dolesunshine.com or doleintlcsr.com. The Dole Promises are from the Dole Asia Holdings group of companies, and apply to their products, which can be seen at sunshineforall.com
1 https://www.mercycorps.org/blog/quick-facts-global-hunger#global-hunger
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200630005347/en/
Contact information
MEDIA CONTACT:
Brittney Theriault
btheriault@golin.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
